Search Options Stock News and Analysis from Schaeffer's

Pharma Stock Rises on Cleared Schizophrenia Treatment

https://www.schaeffersresearch.com/content/news/2024/09/27/pharma-stock-rises-on-cleared-schizophrenia-treatment

9/27/2024 11:43 AM

Bristol-Myers Squibb Co (NYSE:BMY) is up 3.2% at $51.71, after the U.S. Food & Drug Administration (FDA) approved the pharma name's schizophrenia treatment, Cobenfy. This marks the first new treatme...

Analyst: Positive Catalysts Can't Save This Pharma Stock

https://www.schaeffersresearch.com/content/news/2024/02/06/analyst-positive-catalysts-cant-save-this-pharma-stock

2/6/2024 9:00 AM

Biopharmaceutical stock Bristol-Myers Squibb Co (NYSE:BMY) is in focus this morning, after a downgrade to "neutral" from "buy" at Redburn-Atlantic. The analyst in coverage also lowered its price targe...

Bristol-Meyers Stock Seeing Layers of Pressure

https://www.schaeffersresearch.com/content/analysis/2024/01/23/bristol-meyers-stock-seeing-layers-of-pressure

1/23/2024 2:48 PM

After eight-straight monthly losses starting in April 2023, the shares of pharmaceutical concern Bristol-Meyers Squibb Co (NYSE:BMY) started to rebound in December, though were swiftly rejected by the...

Wall Street Wraps Winning Year With Big Plans For 2024

https://www.schaeffersresearch.com/content/news/2023/12/29/wall-street-wraps-winning-year-with-big-plans-for-2024

12/29/2023 2:59 PM

Despite the low-volume, post-Christmas trading environment, where headlines are few and far between, there was plenty to unpack for the final week of 2023. The Dow Jones Industrial Average (DJI) co...

Acquisitions Push 2 Pharma Stocks in Opposite Directions

https://www.schaeffersresearch.com/content/news/2023/12/26/acquisitions-push-2-pharma-stocks-in-opposite-directions

12/26/2023 10:24 AM

Pharmaceutical giants AstraZeneca plc (NASDAQ:AZN) and Bristol-Myers Squibb Co (NYSE:BMY) announced new acquisitions today. The former acquired China's Gracell Biotechnologies (GRCL) for $1.2 bill...

PEOPLE ALSO SEARCH FOR